BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 A$
0,00%
(0,00) 1K
19-noy, 16:10:03 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
27,63 mln
Oʻrtacha hajm
11,81 mln
Hajmi
2,69 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
27,63 mln
Oʻrtacha hajm
11,81 mln
Hajmi
2,69 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business Insider
·
19 daqiqa oldin
Why Morgan Stanley Says the S&P 500 Is Poised to Jump 18%
The Motley Fool
·
37 daqiqa oldin
Is Investing in an S&P 500 ETF Really Enough? Here's My Honest Take.
Barron's
·
10 soat oldin
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida